Dr. Maria E. (“Marién”) Solesio was trained in Spain, where she earned her PharmD in 2008 and her PhD in Neuropharmacology in 2013. The main focus of her PhD dissertation was the study of mitochondrial dysfunction in pharmacological models of Parkinson’s and Huntington’s disease. During her PhD studies, she visited the laboratory of Dr. Mike P. Murphy, in Cambridge, UK, where she trained in the use of mitochondrial-addressed antioxidants. In July 2013, just after graduation, she joined New York University (NYU) for her postdoctoral training, thanks to a competitive fellowship sponsored by the Spanish Ministry of Health. At NYU, she worked for a year under the supervision of Dr. Blas Frangione, at the laboratory of Dr. Silvia Fossati. In July 2014, she joined the laboratory of Dr. Evgeny V. Pavlov, also at NYU, where she conducted her second postdoctoral training until September 2019. During that time, she visited the laboratory of Dr. Ursula Jakob, at the University of Michigan, where she trained in protein biology techniques.

In May of 2018, Dr. Solesio was awarded a K99/R00 Pathway to Independence Award by NIA/NIH. Thanks to those funds and the generous start-up package offered by Rutgers University, she was able to establish her own laboratory at Rutgers University, where she is currently a Faculty member in the Department of Biology. Since her arrival at Rutgers, she has secured major funding (NIH, NSF, and AHA), and published scientific manuscripts as the single corresponding author. In July of 2025, she secured promotion to Associate Professor and tenure. Dr. Solesio’s main research focus during her career has always been the study of mitochondrial physiology and dysfunction in neurodegeneration and aging. She is especially interested in the role of mitochondrial polyP in the dysfunction
of the organelle.

Post-Doctoral Researchers

See what they’re up to!